SCHEMBL8433432

SCHEMBL8433432

CCCC(=O)ON1CCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 4/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
RAB9A P51151 3/20 0.33
FFAR3 O14843 2/20 0.33
HDAC3 O15379 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
NPC1 O15118 2/20 0.33
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC18A3 Q16572 1/20 0.33
ATM Q13315 1/20 0.32
TSHR P16473 1/20 0.32
MAPT P10636 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220296 1.00 ALDH1A1 (0.46) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL4124283 0.98 ALDH1A1 (0.44) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL27474184 0.96 ALDH1A1 (0.43) ALDH1A1L3MBTL1MEN1KMT2ATDP1
Hydrochloric Acid SCHEMBL28611075 0.96 ALDH1A1 (0.43) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL1535851 0.91
SCHEMBL28413576 0.88 L3MBTL1 (0.46) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL8430106 0.86 L3MBTL1 (0.53) L3MBTL1MEN1KMT2ATDP1CES2
SCHEMBL5874880 0.86 L3MBTL1 (0.47) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL8431983 0.84 L3MBTL1 (0.52) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL8430031 0.84 L3MBTL1 (0.52) ALDH1A1L3MBTL1MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958817-A1 COMPOSITION CONTAINING DIARYLALKANE DERIVATIVE AS THE ACTIVE INGREDIENT FOR TREATING OR PREVENTING PANCREATITIS SANKYO COMPANY LIMITED (JP) 1999-11-24 EP disclosed
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
EP-0790235-A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses SANKYO COMPANY LIMITED (JP) 1997-08-20 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed